Table 4. Histological findings in patients with EPS (post-transplantation EPS and classical EPS) in the study population of the Netherlands and Germany; Fibrosis (0, 1 vs. 2, 3), Fibroblast-like-cells (FLC) (0, 1 vs. 2, 3), Exudation (0, 1 vs. 2, 3), Mesothelial denudation (0 vs. 1), Acellular areas (0 vs. 1), Cellularity (0, 1 vs. 2, 3), Vessel density (0, 1 vs. 2, 3), Acute inflammation (0, 1 vs. 2, 3), Chronic inflammation (0, 1 vs. 2, 3), Vasculopathy (0 vs. 1), Hemorrhage (0, 1 vs. 2, 3), Fibrin deposits (0, 1 vs. 2, 3), Calcification (0 vs. 1), Iron deposits (0 vs. 1), Ossification (0 vs. 1), Podoplanin vascular (0, 1 vs. 2, 3), Podoplanin avscular (0, 1 vs. 2, 3).
Variable | Netherlands (n = 18) | Germany (n = 38) | p |
Fibrosis | 2/16 | 1/37 | 0.2 |
FLC | 10/8 | 14/24 | 0.3 |
Exudation | 8/10 | 18/20 | 1 |
Mesothelial denudation | 0/18 | 0/38 | 0.3 |
Acellular areas | 13/5 | 24/14 | 0.6 |
Cellularity | 6/12 | 14/24 | 1 |
Vessel density | 3/15 | 11/38 | 0.5 |
Acute inflammation | 14/4 | 33/5 | 0.4 |
Chronic inflammation | 11/7 | 18/20 | 0.4 |
Vasculopathy | 5/13 | 6/32 | 0.3 |
Hemorrhage | 12/6 | 20/18 | 0.8 |
Fibrin deposits | 9/9 | 12/26 | 0.2 |
Calcification | 18/0 | 33/5 | 0.2 |
Iron deposits | 4/14 | 17/21 | 0.1 |
Ossification | 0/0 | 0/0 | 1 |
Podoplanin vascular | 13/5 | 20/18 | 0.2 |
Podoplanin avascular | 9/9 | 12/26 | 0.2 |